Cardiovascular diseases (CVDs) are the leading cause of premature death and disability in
humans and their incidence is on the rise globally. Given their substantial contribution …

Historically, most patients who required parenteral anticoagulation received heparin,
whereas those patients requiring oral anticoagulation received warfarin. Due to the narrow …

Background Severe COVID‐19 disease is associated with thrombotic complications and
extensive fibrin deposition. This study investigates whether the hemostatic complications in …

Introduction Thrombolysis for acute ischemic stroke (AIS) with alteplase is the currently
approved therapy for patients who present within 4.5 h of symptom onset and meet criteria …

Objetivo Identificar as evidências quanto à infecção pelo SARS-CoV-2 e óbitos dos
profissionais de saúde e fatores de risco relacionados. Métodos Realizou-se uma revisão …

The cornerstone of acute ischemic stroke treatment relies on rapid clearance of an offending
thrombus in the cerebrovascular system. There are various drugs and different methods of …

For several decades, researchers have used erythrocytes for drug delivery of a wide variety
of therapeutics in order to improve their pharmacokinetics, biodistribution, controlled release …

Engineering microorganisms capable of simultaneously accumulating multiple products are
economically attractive for biotechnology. Polyhydroxyalkanoates (PHA) or microbial …

Despite continued achievements in antithrombotic pharmacotherapy, difficulties remain in
managing patients at high risk for both thrombosis and hemorrhage. Utility of antithrombotic …

Background: Escherichia coli (E. coli) is the most extensively used host for the production of
recombinant proteins. However, most of the eukaryotic proteins are typically obtained as …